-Naibedya Chattopadhyay Researcher Activity Profile

Research Author Detailed Information 

Naibedya Chattopadhyay Publication Rate By Year

Naibedya Chattopadhyay has published 1 paper(s) in 2004, 1 paper(s) in 2005, 3 paper(s) in 2007, 2 paper(s) in 2008, for a total of 7 research publications in total.

Naibedya N Chattopadhyay Author Information

LAST NAME: chattopadhyay

FIRST NAME: naibedya

INITIALS: N

AFFILIATION:

Papers

Naibedya Chattopadhyay's Publication Record

1. Transforming growth factor beta receptor family ligands inhibit hepatocyte growth factor synthesis and secretion from astrocytoma cells. Year Published: 2004
Division of Endocrinology, Diabetes and Hypertension and Membrane Biology Program, Brigham and Women's Hospital, Harvard Medical School, 221 Longwood Avenue, Rm 205, Boston, MA 02115, USA. Naibedya@rics.bwh.harvard.edu
2. Functional expression of beta-chemokine receptors in osteoblasts: role of regulated upon activation, normal T cell expressed and secreted (RANTES) in osteoblasts and regulation of its secretion by osteoblasts and osteoclasts. Year Published: 2005
Division of Endocrinology, Diabetes, and Hypertension, Department of Medicine and Membrane Biology Program, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA.
3. Cell growth inhibitory action of an unusual labdane diterpene, 13-epi-sclareol in breast and uterine cancers in vitro. Year Published: 2007
Division of Medicinal and Process Chemistry, Central Drug Research Institute, Lucknow, India.
4. Cell growth inhibitory action of an unusual labdane diterpene, 13-epi-sclareol in breast and uterine cancers in vitro. Year Published: 2007
Division of Medicinal and Process Chemistry, Central Drug Research Institute, Lucknow, India. sadhidhar123@rediffmail.com
5. Recent updates on the calcium-sensing receptor as a drug target. Year Published: 2008
Division of Endocrinology, C.D.R.I., Lucknow, India. ritu_pgi@yahoo.com.
6. Cell growth inhibitory action of an unusual labdane diterpene, 13-epi-sclareol in breast and uterine cancers in vitro. Year Published: 2007
Division of Medicinal and Process Chemistry, Central Drug Research Institute, Lucknow, India. sadhidhar123@rediffmail.com
7. Recent updates on the calcium-sensing receptor as a drug target. Year Published: 2008
Division of Endocrinology, Central Drug Research Institute, Chattar Manzil, Lucknow, India. ritu_pgi@yahoo.com